ArticleBone2026
NOTCH3 disrupts the osteoblast transcriptome in femoral bone of 1-month-old male C57BL/6 mice.
Article in Bone, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Notch signaling plays a fundamental role in skeletal physiology, and activation of NOTCH3 in osteoblasts/osteocytes impairs corticalization, causes cortical osteopenia and suppresses cancellous bone remodeling. To address possible mechanisms responsible, we explored transcriptome profiles in osteocytes and femoral bone from 1-month-old male C57BL/6 mice following activation of NOTCH3 in Dmp1-expressing cells. We used a NOTCH3 gain-of-function mouse line expressing the NOTCH3 intracellular domain (N3ICD) from the Rosa26 locus (R26-N3ICD mice) following the deletion of a loxP flanked STOP cassette, which was accomplished by crossing R26-N3ICD mice with Dmp1-Cre transgenics. Bulk RNA-Sequencing (RNA-Seq) of osteocytes revealed that expression of the N3ICD enhanced pathways associated with rheumatoid arthritis signaling, osteoclast differentiation, collagen degradation and the immune response. Single cell (sc)RNA-Seq of femoral bone from 1-month-old mice revealed clusters of cells related to vascular and osteogenic cells. Trajectory analysis showed a close association among selected clusters in control and N3ICD-expressing femurs. There were modest differences between N3ICD-expressing and control cells in cluster allocation, except for a decrease in the osteogenic cluster in N3ICD-induced cells. Analysis of intron/exon sequences demonstrated that NOTCH3 altered the velocity of the osteogenic cluster. In conclusion, NOTCH3 enhances the activity of selected pathways including osteoclast differentiation and suppresses the transcription of osteogenic cells in femoral bone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.